Earnings Preview: NRX Pharmaceuticals
Portfolio Pulse from Benzinga Insights
NRX Pharmaceuticals (NASDAQ:NRXP) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a pattern of EPS misses followed by share price increases. The stock is currently trading at $0.31, down 58.05% over the last 52-week period.

August 11, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
NRX Pharmaceuticals is expected to report an EPS of $-0.14. Despite past EPS misses, the company's share price has often increased. However, the stock is down 58.05% over the last 52 weeks.
The company's earnings report is a key event that could impact its stock price. Despite past EPS misses, the company's share price has often increased, suggesting that investors may be focusing more on other factors such as guidance. However, the stock's poor performance over the past year indicates that there are likely other negative factors at play.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100